Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles

References

• SunQ, ZhouZ, QiuN, ShenY. Rational design of cancer nanomedicine: nanoproperty integration and synchronization. Adv Mater. 2017;29(14).
   Web of Science ®Google Scholar
• MaZ, LiJ, LinK, et al. Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy. Nat Commun. 2020;11(1):4615. doi:10.1038/s41467-020-18399-432934241
   PubMed Web of Science ®Google Scholar
• KobayashiH, ChoykePL. Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy. Nanoscale. 2016;8(25):12504–12509. doi:10.1039/C5NR05552K26443992
   PubMed Web of Science ®Google Scholar
• LukBT, ZhangL. Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis. ACS Appl Mater Interfaces. 2014;6(24):21859–21873. doi:10.1021/am503622525014486
   PubMed Web of Science ®Google Scholar
• LanH, ZhangW, JinK, LiuY, WangZ. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective. Drug Deliv. 2020;27(1):1248–1262. doi:10.1080/10717544.2020.180955932865029
   PubMed Web of Science ®Google Scholar
• JainRK. Determinants of tumor blood flow: a review. Cancer Res. 1988;48(10):2641–2658.3282647
   PubMed Web of Science ®Google Scholar
• JacobetzMA, ChanDS, NeesseA, et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2013;62(1):112–120. doi:10.1136/gutjnl-2012-30252922466618
   PubMed Web of Science ®Google Scholar
• KonerdingMA, MiodonskiAJ, LametschwandtnerA. Microvascular corrosion casting in the study of tumor vascularity: a review. Scanning Microsc. 1995;9(4):1233–1243, 1243–1244.
   Google Scholar
• KolacnaL, BakesovaJ, VargaF, et al. Biochemical and biophysical aspects of collagen nanostructure in the extracellular matrix. Physiol Res. 2007;56(Suppl 1):S51–S60.17552894
   PubMed Web of Science ®Google Scholar
• LeventalKR, YuH, KassL, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139(5):891–906. doi:10.1016/j.cell.2009.10.02719931152
   PubMed Web of Science ®Google Scholar
• JainRK, StylianopoulosT. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653–664. doi:10.1038/nrclinonc.2010.13920838415
   PubMed Web of Science ®Google Scholar
• BouzinC, FeronO. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery. Drug Resist Updat. 2007;10(3):109–120. doi:10.1016/j.drup.2007.03.00117452119
   PubMed Web of Science ®Google Scholar
• BoucherY, JainRK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res. 1992;52(18):5110–5114.1516068
   PubMed Web of Science ®Google Scholar
• SchudelA, ChapmanAP, YauMK, et al. Programmable multistage drug delivery to lymph nodes. Nat Nanotechnol. 2020;15(6):491–499. doi:10.1038/s41565-020-0679-432523099
   PubMed Web of Science ®Google Scholar
• StylianopoulosT, MartinJD, ChauhanVP, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012;109(38):15101–15108. doi:10.1073/pnas.121335310922932871
   PubMed Web of Science ®Google Scholar
• ChenH, ZhangW, ZhuG, XieJ, ChenX. Rethinking cancer nanotheranostics. Nat Rev Mater. 2017;2(7). doi:10.1038/natrevmats.2017.24
   Web of Science ®Google Scholar
• LinJ, YinQ, ChenB, et al. A magnetism/laser-auxiliary cascaded drug delivery to pulmonary carcinoma. Acta Pharm Sin B. 2020;10(8):1549–1562. doi:10.1016/j.apsb.2019.12.01732963949
   PubMed Web of Science ®Google Scholar
• FonsecaC, SimoesS, GasparR. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release. 2002;83(2):273–286. doi:10.1016/S0168-3659(02)00212-212363453
   PubMed Web of Science ®Google Scholar
• HillLE, TaylorTM, GomesC. Antimicrobial efficacy of poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped cinnamon bark extract against Listeria monocytogenes and Salmonella typhimurium. J Food Sci. 2013;78(4):N626–N632. doi:10.1111/1750-3841.1206923464835
   PubMed Web of Science ®Google Scholar
• CirpanliY, BilensoyE, LaleDA, CalisS. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Eur J Pharm Biopharm. 2009;73(1):82–89. doi:10.1016/j.ejpb.2009.04.01319442723
   PubMed Web of Science ®Google Scholar
• TrapaniG, LopedotaA, BoghetichG, et al. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin. Int J Pharm. 2003;268(1–2):47–57. doi:10.1016/j.ijpharm.2003.08.01614643976
   PubMed Web of Science ®Google Scholar
• HoBN, PfefferCM, SinghA. Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer Res. 2017;37(11):5975–5981. doi:10.21873/anticanres.1204429061776
   PubMed Web of Science ®Google Scholar
• WinKY, FengSS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26(15):2713–2722. doi:10.1016/j.biomaterials.2004.07.05015585275
   PubMed Web of Science ®Google Scholar
• KirbySM, AnnaSL, WalkerLM. Effect of surfactant tail length and ionic strength on the interfacial properties of nanoparticle-surfactant complexes. Soft Matter. 2017;14(1):112–123. doi:10.1039/C7SM01806A29214259
   PubMed Web of Science ®Google Scholar
• MaedaH, BharateGY, DaruwallaJ. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2009;71(3):409–419. doi:10.1016/j.ejpb.2008.11.01019070661
   PubMed Web of Science ®Google Scholar
• MaedaH, NakamuraH, FangJ. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev. 2013;65(1):71–79. doi:10.1016/j.addr.2012.10.00223088862
   PubMed Web of Science ®Google Scholar